drug
Cutaquig
Marketedupdated 3mo agoby $PFE PFIZER INC
Approvedcommunity read0 votes
Unknown drug with a maximum clinical stage of Approval (across all indications), with 11 approved and 56 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying Cutaquig
- phase3A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- phase3Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults
- —Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency.
- phase3Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 14m ago
Found something off?
comments(0)
5-min edit window · permanent after that